SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $84 | -99.9% | 94,796 | +76.5% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | -90.0% | 53,722 | -87.1% | 0.00% | -88.9% |
| Q2 2022 | $838,000 | +289.8% | 416,816 | +801.3% | 0.01% | +800.0% |
| Q4 2021 | $215,000 | -74.3% | 46,245 | -57.9% | 0.00% | -75.0% |
| Q3 2021 | $838,000 | +581.3% | 109,877 | +766.7% | 0.00% | +300.0% |
| Q2 2021 | $123,000 | -65.9% | 12,677 | -70.9% | 0.00% | -50.0% |
| Q1 2021 | $361,000 | +128.5% | 43,628 | +88.1% | 0.00% | +100.0% |
| Q4 2020 | $158,000 | -89.1% | 23,195 | -82.2% | 0.00% | -88.9% |
| Q3 2020 | $1,455,000 | +493.9% | 130,470 | +234.2% | 0.01% | +350.0% |
| Q2 2020 | $245,000 | +191.7% | 39,042 | -14.1% | 0.00% | +100.0% |
| Q1 2020 | $84,000 | +200.0% | 45,447 | +245.6% | 0.00% | – |
| Q3 2019 | $28,000 | -50.0% | 13,149 | +2.9% | 0.00% | – |
| Q3 2018 | $56,000 | -56.9% | 12,774 | -29.4% | 0.00% | -100.0% |
| Q2 2018 | $130,000 | – | 18,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |